CRS Clinical Research Services Berlin GmbH
Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2026
hVIVO acquires CRS Clinical Research Services Berlin
hVIVO plc announced the acquisition of the entire issued share capital of CRS Clinical Research Services Berlin GmbH, a specialist Phase I/II clinical research unit focused on dermatology and women's health, for initial consideration of €0.025 million plus a three-year revenue-based earnout expected to total approximately €6 million in cash.